FPCP
GSK icon

Fort Point Capital Partners’s GSK GSK Stock Holding History

Fort Point Capital Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,022
Closed -$219K – 283
2022
Q1 		$219K Hold
4,022
– – 0.03% 266
2021
Q4 		$222K Buy
+4,022
New +$209K 0.03% 262

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fort Point Capital Partners's GSK Position: Q2 2022 in Review

Fort Point Capital Partners sold out of GSK (GSK) in Q2 2022, closing a stake of 4,022 shares — an estimated $219K sold.

Fort Point Capital Partners first reported a position in GSK in Q4 2021 and held it in 2 quarters. The position peaked at $222K in Q4 2021. 900 funds tracked by Wall St. Rank hold GSK as of Q2 2022.

  • Fort Point Capital Partners reported no remaining GSK position as of Q2 2022 after selling out during the quarter.
  • Fort Point Capital Partners sold 4,022 GSK shares in Q2 2022, an estimated $219K.
  • Fort Point Capital Partners first reported a position in GSK in Q4 2021 and held it in 2 quarters.
  • Fort Point Capital Partners's GSK position peaked at $222K in Q4 2021.
  • 900 funds tracked by Wall St. Rank held GSK as of Q2 2022.

Based on Fort Point Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.